sisunatovir
oral lung penetrant RSV fusion inhibitor Ph. II candidate (50 mg BID) for RSV infect. opt. from literature starting point J. Med. Chem., Mar. 17, 2021 Reviral Ltd, Hertfordshire, UK
Molecules of the Month - March 2021
Molecules of the Month
- LSN3318839
- GLPG1972
- APJ compound 14
- encequidar
- S62798 (Servier)
- CVN424
- ABBV-167
- GDC-0310
- "compound 72"
- "compound 20"
- TAK-418
- compound 13 (GSK716)
- RBN-012759
- sisunatovir